The Drug Hunter’s Assistant: Accelerating Drug Discovery With AI
Are The High Expectations Justified?
The hype around Artificial Intelligence has been deafening in recent years, but real progress can only come when drug discovery culture and regulators catch up with the technology.
You may also be interested in...
Focusing too much on the US provides a blinkered view of the industry and prevents access to the myriad opportunities on offer globally.
Veklury is now the first US FDA-approved treatment for COVID-19, but its limited benefits means its lifespan as a blockbuster could be short.
Many clinicians doubt that aducanumab can really help slow the decline in Alzheimer’s patients – but US FDA could offer it the benefit of the doubt.